Table: Phoenixbio -Q1 group results

PhoenixBio

12/08/2022 07:30

Aug 12 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2022        Jun 30, 2021     Mar 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              445 mln             452 mln           1.75     
                   (-1.5 pct)                           (+32.2 pct) 
  Operating          89 mln              69 mln           206 mln   
                   (+27.6 pct)                                      
  Recurring          113 mln             73 mln           211 mln   
                   (+54.1 pct)                                      
  Net                103 mln             64 mln           198 mln   
                   (+59.7 pct)                                      
  EPS               31.26 yen           19.69 yen        60.08 yen  
  EPS Diluted       20.76 yen           12.91 yen                   
  Ann Div                                  NIL              NIL     
  -Q2 div                                  NIL              NIL     
  -Q4 div                                  NIL              NIL     
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T